Add time:08/18/2019 Source:sciencedirect.com
BackgroundOur previous work in acute ischemic stroke and TBI models focused on efficacy and pharmacological parameters of cerebrolysin (cas 12656-61-0)®. In this prospective, randomized, blinded, placebo-controlled study we compared efficacy of neuropeptide preparations with putative neurotrophic potential to the reference product Cerebrolysin® by assessing functional outcome and lesion volumes after embolic stroke in a rodent model.
We also recommend Trading Suppliers and Manufacturers of cerebrolysin (cas 12656-61-0). Pls Click Website Link as below: cas 12656-61-0 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View